logo
Search orAI Icon𝛼SK
ENTITY

IN8bio (INAB US)

8
Analysis
Health Care • United States
IN8bio, Inc. operates as a clinical-stage biotechnology company. The Company focuses on developing therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. IN8bio serves customers in the United States.
more
bullish•IN8bio
•17 Jun 2024 22:00•Issuer-paid

INAB: INB-100 Update at EHA24 Ole!

IN8Bio is a clinical-stage, oncology-focused biotechnology company using ?d T cells against solid and hematological tumors. Its pipeline is built...

Logo
Share
bullish•IN8bio
•06 Jun 2024 03:00•Issuer-paid

INAB: INB-200 Update at ASCO24

IN8Bio is a clinical-stage, oncology-focused biotechnology company using ?d T cells against solid and hematological tumors. Its pipeline is built...

Logo
Share
bullish•IN8bio
•20 May 2024 22:00•Issuer-paid

INAB: 1Q:24 Results

IN8Bio is a clinical-stage, oncology-focused biotechnology company using ?d T cells against solid and hematological tumors. Its pipeline is built...

Logo
Share

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7

x